Delivery Order SPE2DB24D1205-SPE2DB25FCZKB
- Not listed
- The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units) with a ceiling value of $11,135.25. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for Talzenna 0.35 mg softgel capsules (30-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle...
- The Defense Logistics Agency (DLA) awarded a $33,405.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.5 mg softgel capsules (30-count units) on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a delivery order under...
- This federal contract award, valued at $12,246.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Talzenna 0.5 mg softgel capsules, a prescription medication, to support federal medical supply requirements. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of May 6, 2025. There is no set-aside designation,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Talzenna 0.5 mg softgel capsules in 30-count packages. The award has a ceiling value of $11,135.25 and is a firm fixed-price contract. The period of performance runs through June 10, 2025. Amerisourcebergen Drug Corp holds a larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 23, 2025, for the supply of Talzenna 0.25 mg softgel capsules (30-count units) to support federal medical procurement needs. This competitively awarded, non-set-aside contract carries a firm fixed price ceiling value of $22,270.52 with an ultimate completion date of October 15, 2025. The award is funded by the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for TALZENNA 0.5 mg softgels (30-count units) with a firm fixed price arrangement. The award, issued on September 4, 2025, is scheduled for completion by September 25, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TALZENNA 0.35 mg softgel capsules (30-count supply) with a ceiling value of $11,135.25 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by October 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $30,008.88, is for the supply of a specialty medication, Talzenna 1 mg capsule, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This award is issued under a larger indefinite delivery contract (IDC) between...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZKBDelivery Order
The Defense Logistics Agency awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp for Talzenna 0.5 mg softgels (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills critical pharmaceutical supply needs for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Talzenna, a prescription oncology medication, exemplifies the company's role as a key vendor in the DLA's pharmaceutical supply chain, supporting military and veteran healthcare requirements through competitively awarded, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 8/11/25 |